Speaker illustration

Professor Harrison Farber

Adelphi Communications, Bollington (United Kingdom of Great Britain & Northern Ireland)

A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Event: ESC CONGRESS 2017

Topic: Chronic pulmonary hypertension

Session: Progress in the management of pulmonary hypertension


This platform is supported by

logo Novo Nordisk